The Concerta shortage in Australia is anticipated to continue until the end of 2025. How are you all managing with ADHD during this time? My heart dropped when I saw this news a few minutes ago. Is there any other online option for purchasing it? I know that if there are alternatives, they’ll probably sell out quickly due to high demand. While I can cope with my Ritalin, it just doesn’t have the same effect for me.

One thought on “Concerta shortage in Aus expected to last until end of 2025, what are you with ADHD doing?”

  1. I completely understand how concerning this shortage is. It’s tough when the medication that works best for you is hard to come by. If you can manage with Ritalin, that’s great, but it’s understandable that it may not have the same effect.

    As for finding Concerta, I would recommend speaking to your doctor or pharmacist about any potential alternatives or temporary solutions. Some online pharmacies do carry it, but be cautious of the legitimacy of any sources you find. Joining support groups or forums could also help you connect with others in similar situations who might have tips or insights on what they’re doing. In the meantime, focusing on other strategies for managing ADHD, like therapy, coaching, or lifestyle adjustments, can be beneficial as well. You’re not alone in this!

Leave a Reply to audadmin Cancel reply

Your email address will not be published. Required fields are marked *


Explore More

Would you pay $40 a month for unlimited films at Event and Hoyts cinemas?

Would you consider paying $40 a month for unlimited movies at Event and Hoyts cinemas? Subscription models for cinemas have gained traction in the US and Europe and have proven

Ex-Tropical Cyclone Alfred downgraded to a tropical low ahead of it making landfall on Saturday morning

Ex-Tropical Cyclone Alfred has been downgraded to a tropical low as it approaches landfall on Saturday morning.

Australia defends Pharmaceutical Benefits Scheme as US companies urge imposing reciprocal tariffs

Australia stands firm on its Pharmaceutical Benefits Scheme as U.S. companies call for the implementation of reciprocal tariffs.